...
首页> 外文期刊>Chemico-biological interactions >Expression of AKR1B1, AKR1C3 and other genes of prostaglandin F2 alpha biosynthesis and action in ovarian endometriosis tissue and in model cell lines
【24h】

Expression of AKR1B1, AKR1C3 and other genes of prostaglandin F2 alpha biosynthesis and action in ovarian endometriosis tissue and in model cell lines

机译:AKR1B1,AKR1C3和其他前列腺素F2基因的表达及其在卵巢子宫内膜异位症组织和模型细胞系中的作用

获取原文
获取原文并翻译 | 示例

摘要

Endometriosis is a frequent benign gynecological disease characterized by endometrial tissue outside the uterine cavity. The estimated prevalence in the general population is 6-10%, but this reaches 30-50% in women with infertility and/or pain. As ectopic tissue within the pelvic cavity provokes inflammation, endometriosis is also considered a chronic inflammatory disease, and is characterized by increased peritoneal fluid levels of prostaglandin (PG)E2 and PGF2 alpha. The AKR1B1 and AKR1C3 enzymes act as PG synthases and catalyze reduction of PGH2 to PGF2 alpha, and PGD2 to 9 alpha,11 beta-PGF2 alpha, respectively. AKR1B1 and AKR1C3 may thus be associated with increased PGF2 alpha, production in endometriosis patients, as supported by our previous report of increased AKR1C1-AKR1C3 mRNA levels in endometriotic tissue, compared to control endometrium. Here, we initially evaluated PGF2 alpha concentrations in peritoneal fluid from endometriosis patients and healthy women. We also examined expression of AKR1B1, AKR1C3 and other genes involved in PGF2 alpha, biosynthesis, metabolism, and action in ovarian endometriosis tissue versus healthy endometrium, and in peritoneal endometriosis and control endometrium model cell lines. Compared to controls, increased PGF2 alpha concentrations in peritoneal fluid of patients were supported by endometriotic tissue showing increased AKR1B1 mRNA and protein levels, but unchanged AKR1C3 protein levels. Among genes involved in PGF2 alpha biosynthesis, metabolism and action PLA2G2A, PTGS2/COX-2, ABCC4 and PTGFR were up-regulated, mRNA levels of SLCO2A, PTGDS and HPGDS were unchanged, and genes PLA2G4A and HPGD were down-regulated in diseased tissue. All of these PGF2 alpha-associated genes were also expressed in control endometrial HIEEC epithelial and HIESC stromal cell lines, and in peritoneal endometriosis 12-Z epithelial and 22-B stromal cell lines. Higher expression of PLA2G2A, PTGS2, AKR1B1, AKR1C3 and ABCC4 was seen in 22-B endometriosis cells compared to HIESC control cells. These cell models characterized in this study will enable further investigations into the role of PGF2 alpha, in the pathophysiology of endometriosis and the involvement of AKR1B1 and AKR1C3. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
机译:子宫内膜异位症是一种常见的良性妇科疾病,其特征是子宫腔外的子宫内膜组织。据估计,普通人群的患病率为6-10%,但在不育和/或疼痛的女性中这一比例达到30-50%。由于盆腔内的异位组织引起炎症,子宫内膜异位也被认为是一种慢性炎症疾病,其特征是前列腺素(PG)E2和PGF2α的腹膜液水平升高。 AKR1B1和AKR1C3酶起PG合酶的作用,分别催化PGH2还原为PGF2α,PGD2还原为9 alpha,11 beta-PGF2 alpha。因此,AKR1B1和AKR1C3可能与子宫内膜异位症患者中PGF2α的产生增加有关,正如我们先前报道的子宫内膜异位症组织中与对照子宫内膜相比AKR1C1-AKR1C3 mRNA水平增加的报道所支持的。在这里,我们最初评估了来自子宫内膜异位症患者和健康女性的腹膜液中PGF2α的浓度。我们还检查了AKR1B1,AKR1C3和其他基因在卵巢子宫内膜异位组织相对于健康子宫内膜以及腹膜子宫内膜异位和控制子宫内膜模型细胞系中的表达,参与PGF2α,生物合成,代谢和作用的其他基因。与对照组相比,子宫内膜异位组织支持患者腹膜液中PGF2α浓度的增加,显示其AKR1B1 mRNA和蛋白水平升高,但AKR1C3蛋白水平不变。在参与PGF2α生物合成,代谢和作用的基因中,PLA2G2A,PTGS2 / COX-2,ABCC4和PTGFR上调,SLCO2A,PTGDS和HPGDS的mRNA水平不变,而PLA2G4A和HPGD基因在患病组织中下调。 。所有这些与PGF2α相关的基因也在对照子宫内膜HIEEC上皮和HIESC基质细胞系以及腹膜子宫内膜异位症12-Z上皮和22-B基质细胞系中表达。与HIESC对照细胞相比,在22-B子宫内膜异位症细胞中发现了PLA2G2A,PTGS2,AKR1B1,AKR1C3和ABCC4的更高表达。这项研究中表征的这些细胞模型将能够进一步研究PGF2α在子宫内膜异位症的病理生理中的作用以及AKR1B1和AKR1C3的参与。 (C)2014 Elsevier Ireland Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号